Stöger, J Lauran <br/><br/>
Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.  [electronic resource] 

 -  Thrombosis and haemostasis  08 2016 
 - 565-77 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH16-01-0043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Atherosclerosis--etiology<br/>Biological Transport, Active<br/>Cholesterol--metabolism<br/>Cholesterol, Dietary--administration & dosage<br/>Disease Models, Animal<br/>Female<br/>Hypercholesterolemia--prevention & control<br/>Inflammation--etiology<br/>Intestinal Mucosa--metabolism<br/>Macrophages--metabolism<br/>Mice<br/>Mice, Knockout<br/>Myeloid Cells--metabolism<br/>Plaque, Atherosclerotic--etiology<br/>Receptors, Interleukin-10--deficiency<br/>Receptors, LDL--deficiency<br/>Signal Transduction<br/>Sterol O-Acyltransferase--metabolism<br/>Sterol O-Acyltransferase 2